GSK Invests £400M in Cambridge R&D Innovation Centre
LONDON, July 30, 2026 GSK has announced plans to establish a new global flagship research and development (R&D) centre...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LONDON, July 30, 2026 GSK has announced plans to establish a new global flagship research and development (R&D) centre...
BOULDER, Colo., July 28, 2026 Ambrosia Biosciences Inc. has strengthened its leadership team and scientific capabilities with the appointment...
LONDON, July 30, 2026 GSK has reported strong Q2 2026 financial results, driven by continued growth across its Specialty...
